iiinova — where your digital self keeps evolving

Reposted by @yilinmdphd.bsky.social

Ajay Major, MD, MBA @majorajay.bsky.social · 29/05/2025

Announcing the 1st paper of ‪@thelancethaem.bsky.social‬ Commission on Adverse Events, with Drs. @biostatgirl.bsky.social‬ & Thanarajasingam. We review advances in measuring & reporting newly-described AEs and provide analytic & AE visualization tools for dissemination. buff.ly/SchRHhq Thread ⬇️🧵

133

Reposted by @yilinmdphd.bsky.social

Eddie Cliff @eddiecliff.bsky.social · 31/05/2025

What steps can trialists, regulators, journals, editors, reviewers, sponsors & academics take to improve toxicity reporting & identification? 👇 check out this figure from our @thelancethaem.bsky.social adverse event commission www.thelancet.com/journals/lan... @broeckelmann.bsky.social

011

Reposted by @yilinmdphd.bsky.social

Science News @scinews.bsky.social · 17/05/2025

AI for research: the ultimate guide to choosing the right tool "Curious about using artificial intelligence to boost your research? Here are the programs you shouldn’t miss." www.nature.com/articles/d41...

0103

yilinmdphd.bsky.social @yilinmdphd.bsky.social · 12/04/2025

#iwCART25 day 1 covered current state of #CellTherapy in solid tumors, CLL & ALL. Day 2 opens with activities in the next frontier: autoimmune disorders. @vjhemonc.bsky.social keynote speaker Dr. David Porter.

020

Reposted by @yilinmdphd.bsky.social

OncoDaily @oncodaily.bsky.social · 08/03/2025

Women Cancer Advocates: Champions of Hope and Inspiration🎗️ 🌍This International Women’s Day, we honor eight inspiring women, including late and living celebrities, who have advocated for early cancer detection and prevention through collaborations with health organizations.

2112

yilinmdphd.bsky.social @yilinmdphd.bsky.social · 24/02/2025

Bright sunny day in Minnesota to travel to Osaka Japan. Looking forward to international exchange in #CARTtherapy #JSTCT2025

020

yilinmdphd.bsky.social @yilinmdphd.bsky.social · 22/02/2025

Great inaugural #NashvilleHeme25: timely clinical data updates, relevant practical information, fun debates! All at the capitol of country music. Save the date for #NashvilleHeme26

000

yilinmdphd.bsky.social @yilinmdphd.bsky.social · 21/02/2025

Great venue for the inaugural #nashvilleheme25 at Country Music Hall of Fame! Hematologists know how to make CME fun.

010

Reposted by @yilinmdphd.bsky.social

Jan Nolta, PhD @jannolta.bsky.social · 04/02/2025

Our International Society of Cell & Gene Therapy @isctglobal.bsky.social MSC committee has published this statement on the US FDA approval of allogenic Bone Marrow- derived mesenchymal stem/stromal cells. www.sciencedirect.com/science/arti...

sciencedirect.com

ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells

The December 2024 US Food and Drug Administration (FDA) approval of Mesoblast's Ryoncil (remestemcel-L-rknd)—allogeneic bone marrow mesenchymal stroma…

082

yilinmdphd.bsky.social @yilinmdphd.bsky.social · 29/01/2025

I guess the lunar new year luck rubbed off on my son. He passed his driving test. Watch out, Rochester: another teenager on the road!

010

Reposted by @yilinmdphd.bsky.social

American Society of Hematology @ash.hematology.org · 18/12/2024

Relive the excitement of #ASH24 and discover other sides of the Society that pique your interest. The official meeting newscast ASH News TV is online! 📺Watch here: bit.ly/4fhpC56 #HemeSky #Hematology #BloodSky

042

Reposted by @yilinmdphd.bsky.social

Miguel Perales MD @drmiguelperales.bsky.social · 10/12/2024

Happy to welcome #ASTCT to @bsky.app Follow @astct.bsky.social as we prepare for #Tandem25 in Honolulu #bmtsm #CARTcells #genetherapy

0123

yilinmdphd.bsky.social @yilinmdphd.bsky.social · 09/12/2024

Can we avoid the Chekov’Gun Dilemma in #CART therapy decision making? Dr. Rejeski presents prediction model at the time of eval, prior to leukapheresis #ASH24 data from >800 #mmsm pts (abstract 895) @drmiguelperales.bsky.social

051

Reposted by @yilinmdphd.bsky.social

Megan Weivoda, Ph.D. @megvoda.bsky.social · 09/12/2024

Catching up with our Myeloma, Amyloidosis, and Dysproteinemia colleagues across Mayo Clinic sites at #ASH24. @yilinmdphd.bsky.social @leifbergsagel.bsky.social @lbaughn.bsky.social @vincentrk.bsky.social

192

Reposted by @yilinmdphd.bsky.social

American Society of Hematology @ash.hematology.org · 09/12/2024

Airy spheres ascend, Colors dance in vivid light— Come see the bubbles. #ASHaiku #ASH24 Now through 1 p.m. at the amphitheater (bay side of the SDCC) #Hemesky #hematology

041

Reposted by @yilinmdphd.bsky.social

Miguel Perales MD @drmiguelperales.bsky.social · 08/12/2024

#ASH24 #ASHselfies with @ouholter.bsky.social Marcelo Pasquini @bldcancerdoc.bsky.social @yilinmdphd.bsky.social Ryo Nakamura & Veronica Bachanova - great time to reconnect with friends at the poster session

0183

Reposted by @yilinmdphd.bsky.social

Krishna Komanduri @drkomanduri.bsky.social · 08/12/2024

Congrats to Michelle Wang @atulbutte.bsky.social @ucsfcancer.bsky.social for her oral presentation demonstrating utility of #AI to predict outcomes after CAR-T therapy for #lymphoma. Machine learning identified age and four lab values measured within 24h of infusion as predictive of relapse. #ASH24

0103

yilinmdphd.bsky.social @yilinmdphd.bsky.social · 08/12/2024

Activated #CART cell or megakaryocyte? Either way, color matches my shirt 😆 trying to grab #ASH24 souvenir before they are gone!

040

yilinmdphd.bsky.social @yilinmdphd.bsky.social · 06/12/2024

Annual pre-holiday trek to warmer weather and even more exciting exchange #ASH24

010